These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 23135970)

  • 1. Quantitative proteomic analysis to decipher the differential apoptotic response of bortezomib-treated APL cells before and after retinoic acid differentiation reveals involvement of protein toxicity mechanisms.
    Uttenweiler-Joseph S; Bouyssié D; Calligaris D; Lutz PG; Monsarrat B; Burlet-Schiltz O
    Proteomics; 2013 Jan; 13(1):37-47. PubMed ID: 23135970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bortezomib Causes ER Stress-related Death of Acute Promyelocytic Leukemia Cells Through Excessive Accumulation of PML-RARA.
    Takenokuchi M; Miyamoto K; Saigo K; Taniguchi T
    Anticancer Res; 2015 Jun; 35(6):3307-16. PubMed ID: 26026090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
    Altmann A; Markert A; Askoxylakis V; Schöning T; Jesenofsky R; Eisenhut M; Haberkorn U
    J Nucl Med; 2012 Nov; 53(11):1764-71. PubMed ID: 23055533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bortezomib sensitizes human acute myeloid leukemia cells to all-trans-retinoic acid-induced differentiation by modifying the RARα/STAT1 axis.
    Ying M; Zhou X; Zhong L; Lin N; Jing H; Luo P; Yang X; Song H; Yang B; He Q
    Mol Cancer Ther; 2013 Feb; 12(2):195-206. PubMed ID: 23243061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WEB-2086 and WEB-2170 trigger apoptosis in both ATRA-sensitive and -resistant promyelocytic leukemia cells and greatly enhance ATRA differentiation potential.
    Laurenzana A; Cellai C; Vannucchi AM; Pancrazzi A; Romanelli MN; Paoletti F
    Leukemia; 2005 Mar; 19(3):390-5. PubMed ID: 15674364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct apoptotic responses in maturation sensitive and resistant t(15;17) acute promyelocytic leukemia NB4 cells. 9-cis retinoic acid induces apoptosis independent of maturation and Bcl-2 expression.
    Bruel A; Benoit G; De Nay D; Brown S; Lanotte M
    Leukemia; 1995 Jul; 9(7):1173-84. PubMed ID: 7630193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: crosstalk among proteasome, autophagy-lysosome and ER stress.
    Kawaguchi T; Miyazawa K; Moriya S; Ohtomo T; Che XF; Naito M; Itoh M; Tomoda A
    Int J Oncol; 2011 Mar; 38(3):643-54. PubMed ID: 21174067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia.
    Zheng PZ; Wang KK; Zhang QY; Huang QH; Du YZ; Zhang QH; Xiao DK; Shen SH; Imbeaud S; Eveno E; Zhao CJ; Chen YL; Fan HY; Waxman S; Auffray C; Jin G; Chen SJ; Chen Z; Zhang J
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7653-8. PubMed ID: 15894607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapeutic agents in gastric cancer cell lines.
    Bae SH; Ryoo HM; Kim MK; Lee KH; Sin JI; Hyun MS
    Oncol Rep; 2008 Apr; 19(4):1027-32. PubMed ID: 18357392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
    Zhou DC; Hallam SJ; Lee SJ; Klein RS; Wiernik PH; Tallman MS; Gallagher RE
    Cancer Res; 1998 Dec; 58(24):5770-6. PubMed ID: 9865735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of lipoxin A4 in the cell-to-cell interaction between all-trans retinoic acid-treated acute promyelocytic leukemic cells and alveolar macrophages.
    Tsai WH; Shih CH; Wu HY; Chien HY; Chiang YC; Lai SL; Hsu SC; Kou YR; Hsu HC
    J Cell Physiol; 2012 Mar; 227(3):1123-9. PubMed ID: 21567401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of immediate early gene X-1 (IEX-1) is differentially induced by retinoic acids in NB4 and KG1 cells: possible implication in the distinct phenotype of retinoic acid-responsive and -resistant leukemic cells.
    Arlt A; Minkenberg J; Kocs B; Grossmann M; Kruse ML; Fölsch UR; Schäfer H
    Leukemia; 2004 Oct; 18(10):1646-55. PubMed ID: 15306824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cells.
    Tsapakidis K; Vlachostergios PJ; Voutsadakis IA; Befani CD; Patrikidou A; Hatzidaki E; Daliani DD; Moutzouris G; Liakos P; Papandreou CN
    Int J Urol; 2012 Jun; 19(6):565-74. PubMed ID: 22324515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombospondin-1 (TSP-1) and TSP-1-derived heparin-binding peptides induce promyelocytic leukemia cell differentiation and apoptosis.
    Bruel A; Touhami-Carrier M; Thomaidis A; Legrand C
    Anticancer Res; 2005; 25(2A):757-64. PubMed ID: 15868907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia.
    Pahler JC; Ruiz S; Niemer I; Calvert LR; Andreeff M; Keating M; Faderl S; McConkey DJ
    Clin Cancer Res; 2003 Oct; 9(12):4570-7. PubMed ID: 14555532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detrimental effects of proteasome inhibition activity in Drosophila melanogaster: implication of ER stress, autophagy, and apoptosis.
    Velentzas PD; Velentzas AD; Mpakou VE; Antonelou MH; Margaritis LH; Papassideri IS; Stravopodis DJ
    Cell Biol Toxicol; 2013 Feb; 29(1):13-37. PubMed ID: 23161111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells.
    Freitas RA; Silva dos Santos GA; Gimenes Teixeira HL; Scheucher PS; Lucena-Araujo AR; Lima AS; Abreu e Lima RS; Garcia AB; Jordão AA; Falcão RP; Vannucchi H; Rego EM
    Leuk Res; 2009 Jul; 33(7):958-63. PubMed ID: 19013639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells.
    Nawrocki ST; Carew JS; Pino MS; Highshaw RA; Andtbacka RH; Dunner K; Pal A; Bornmann WG; Chiao PJ; Huang P; Xiong H; Abbruzzese JL; McConkey DJ
    Cancer Res; 2006 Apr; 66(7):3773-81. PubMed ID: 16585204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of noncompetitive proteasome inhibition on bortezomib resistance.
    Li X; Wood TE; Sprangers R; Jansen G; Franke NE; Mao X; Wang X; Zhang Y; Verbrugge SE; Adomat H; Li ZH; Trudel S; Chen C; Religa TL; Jamal N; Messner H; Cloos J; Rose DR; Navon A; Guns E; Batey RA; Kay LE; Schimmer AD
    J Natl Cancer Inst; 2010 Jul; 102(14):1069-82. PubMed ID: 20505154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differentiation and apoptosis of NB4 cells synergistically induced by Tanshinone II A and all-trans retinoic acid].
    Liu ZG; Yang YM; Meng WT; Huang CL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):788-91. PubMed ID: 15573755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.